Open Access Week

October 25 -31, 2021 | Everywhere

Pranab Chatterjee
  • Kolkata
  • India
  • Yes--definitely!
Share on Facebook Share
  • Blog Posts (3)
  • Discussions
  • Events
  • Groups
  • Photos
  • Photo Albums
  • Videos

Pranab Chatterjee's Friends

  • Donna Okubo


Testing WordPress to for Podcasting my Blog

Testing out the recent connection with, which lets you create podcasts from the content created on your wordpress-powered blog!

How long does SARS-CoV-2 survive on different surfaces?

One question which has been doing the rounds is if one can catch COVID-19 from fomites. I summarize the findings from a piece published in NEJM a few weeks back.

Was the SARS-CoV-2 a laboratory generated virus?

Summary information from some recent publications which indicate that the SARS-CoV-2 most likely emerged in nature, through natural selection, and was not a laboratory generated virus which escaped from the lab, either accidentally or due to malicious intent, and resulted in the pandemic which has thrown the whole world off-balance. However, the debate still remains, and a clear, fool proof evidence in favor of either side is yet to be identified.

Where did SARS-CoV-2 come from?

Some thoughts on the origin of the SARS-COV-2 virus. I understand that this field of knowledge is changing continuously and if anything in here is outdated or if there have been any new breakthroughs, please leave a comment and share with me!

Some Thoughts on COVID-19 Infection Mortality Rate

Some thoughts on the COVID-19 mortality, which seems to be on the decline in India as of the last six weeks or so.

Pranab Chatterjee's Page

Profile Information

Are you participating in OAWeek 2020? (You can update this later)
First name
Last name
Organization/institution name
Medical College and Hospital, Kolkata
Type of institution
Academic Institution
What's your position?
Student, Other
What's the level of OA awareness where you are?
What are your goals for OA Week?
Spread the word about the need for getting more research and scholarly publications (especially reviews and meta-analyses, which have a high impact on the clinical practice in developing nations) out in the open! Go OA!

Comment Wall

You need to be a member of Open Access Week to add comments!

Join Open Access Week

  • No comments yet!

Pranab Chatterjee's Blog

Guerilla Open Access: To Be or Not To Be?

Aaron Swartz, Greg Maxwell, et al have been vocal in their support of guerilla open access. While I am all for open access (or else why would I be here, right?), I have my share of doubts regarding the issue of embracing illegal methods to further the cause of open access.

In my third post in the series of posts, celebrating this year's open access week, I take a look into the issue of guerilla open access and why I do not think this is the panacea we are looking for.

Check out…


Posted on October 27, 2011 at 9:33am

Make hay when the sun shines!

Not everything is peachy in the world of Open Access publication, and in this next post, I tackle the issue of predatory open access. I have kept it short intentionally mainly because the issue is not something I want too many people to get too suspicious about and hence send out a wrong impression about the whole deal of Open Access. But, at the same time, I want everyone to be aware of what they are getting themselves into and not get duped by posers who are setting the open access…


Posted on October 26, 2011 at 12:57pm

Celebrating Open Access Week on My Blog

Since I am out of medical school now, it is difficult to organize the on-ground events. However, this time around, I am going to celebrate OAW by writing about it on my online profiles. 


Check out my opening post on the issue:  So, You Hit A Paywall?


Hope you enjoy reading it. Cheers!

Posted on October 25, 2011 at 12:13pm


Organized by:

in partnership with our
Advisory Committee

Twitter Feed

All content subject to a Creative Commons Attribution 4.0 License unless specified differently by poster.   Created by Nick Shockey.   Powered by

Badges  |  Report an Issue  |  Terms of Service